Skip navigation

Development and Implementation of Novel Technologies to Remove Bottlenecks, Streamline Development, and Reduce Costs

June 21-22, 2018
  • San Diego, CA

To help overcome the growing demands to lower costs and increase productivity, pharmaceutical/ biotech companies must live on the cutting edge of the separation sciences and deploy next generation solutions to alleviate current, and prevent future, downstream bottlenecks. CBI’s Disruptive Downstream Technologies (DDT) showcases next-generation, platforms and approaches to keep your company competitive.

Learn scientific principles from industry experts and academics who are currently revolutionizing biologic development and manufacturing. Participate at CBI’s intimate, solutions-driven forum to bring industry defining and cost effective strategies to your manufacturing facilitates.

Together as a community we will share new ideas, solutions and lessons learned to accelerate the development and implementation of these transformative technologies. Let CBI help you prepare for the next wave of modalities and increasingly diversified pipelines.

DRIVERS AND DISRUPTIONS IN
DOWNSTREAM BIOPROCESSING:

  • Intensification of mAb Downstream Processes Using Impurity Precipitation Strategies
  • Identification and Removal of Problematic Host Cell Proteins in CHO Bioprocessing
  • Process intensification and Characterization to Enable Expedited Programs
  • Increase Batch Yield and Improve Efficiency Using Advanced Statistics, Analytics and High-Throughput Process Development
  • De-Risking New Technology to Push Innovative Ideas Ahead — Strategies to Accelerate Technology Adoption

Disruptive Downstream Technologies

Development and Implementation of Novel Technologies to Remove Bottlenecks, Streamline Development, and Reduce Costs

To help overcome the growing demands to lower costs and increase productivity, pharmaceutical/ biotech companies must live on the cutting edge of the separation sciences and deploy next generation solutions to alleviate current, and prevent future, downstream bottlenecks. CBI’s Disruptive Downstream Technologies (DDT) showcases next-generation, platforms and approaches to keep your company competitive.

Learn scientific principles from industry experts and academics who are currently revolutionizing biologic development and manufacturing. Participate at CBI’s intimate, solutions-driven forum to bring industry defining and cost effective strategies to your manufacturing facilitates.

Together as a community we will share new ideas, solutions and lessons learned to accelerate the development and implementation of these transformative technologies. Let CBI help you prepare for the next wave of modalities and increasingly diversified pipelines.

DRIVERS AND DISRUPTIONS IN
DOWNSTREAM BIOPROCESSING:

  • Intensification of mAb Downstream Processes Using Impurity Precipitation Strategies
  • Identification and Removal of Problematic Host Cell Proteins in CHO Bioprocessing
  • Process intensification and Characterization to Enable Expedited Programs
  • Increase Batch Yield and Improve Efficiency Using Advanced Statistics, Analytics and High-Throughput Process Development
  • De-Risking New Technology to Push Innovative Ideas Ahead — Strategies to Accelerate Technology Adoption